Objective To compare the administration cost of glargine and neutral protamine hagedorn in glycemic control.
目的比较住院患者使用甘精胰岛素和中性鱼精蛋白锌胰岛素控制血糖达标的成本。
The principal advantage of insulin Glargine over neutral protamine Hagedorn (NPH) insulin is in a lower frequency of hypoglycemic reactions, thus affording improved safety.
甘精胰岛素较中性鱼精蛋白锌胰岛素的主要优势是较少发生低血糖反应，从而具有较好的安全性。
The principal advantage of insulin Glargine over neutral protamine Hagedorn (NPH) insulin is in a lower frequency of hypoglycemic reactions, thus affording improved safety.
甘精胰岛素较中性鱼精蛋白锌胰岛素的主要优势是较少发生低血糖反应，从而具有较好的安全性。
应用推荐